MORGAN STANLEY PLC/CALL/ZOETIS/170/0.1/17.01.25 | Real-time Bid/Ask 08:22:38 2024-07-04 EDT | ||
| 1.95 EUR / 2.04 EUR | +3.37% |
|
| Current month | -1.53% | ||
| 1 month | +4.89% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
Latest news about ZOETIS INC.
| Date | Price | Change |
|---|---|---|
| 24-07-04 | 1.94 | +0.52% |
| 24-07-03 | 1.93 | +2.12% |
| 24-07-02 | 1.89 | +6.78% |
| 24-07-01 | 1.77 | -9.69% |
| 24-06-28 | 1.96 | -2.49% |
Delayed Quote Börse Stuttgart
Last update July 04, 2024 at 04:12 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ZOETIS INC. |
| Issuer | Morgan Stanley |
| WKN | MB3540 |
| ISIN | DE000MB35402 |
| Date issued | 2023-02-02 |
| Strike | 170 $ |
| Maturity | 2025-01-17 (197 Days) |
| Parity | 10 : 1 |
| Emission price | 3.24 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.6 € |
|---|---|
| Lowest since issue | 0.79 € |
| Spread | 0.09 € |
| Spread % | 4.41% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
175.6
USD
Average target price
210.2
USD
Spread / Average Target
+19.68%
- Stock Market
- Warrants
- Warrant
